If you read this blog you know that I like stem cell contests and giving out awards. In the latest contest I am teaming up with ISSCR. The winner of the contest will receive a free registration to the upcoming ISSCR 2014 Annual Meeting in beautiful Vancouver, B.C. How do you enter and possibly win? […]
Win Free ISSCR 2014 Meeting Registration Read More »
Congratulations to my new friends Paolo Bianco, M.D., of Sapienza University of Rome (pictured at left), Elena Cattaneo, Ph.D., of University of Milan and Michele De Luca, M.D. of University of Modena and Reggio Emilia (photo in the middle of the post), for receiving the 2014 ISSCR Public Service Award. Drs. Bianco, Cattaneo, and De Luca are
Congrats to Bianco, Cattaneo, & De Luca for ISSCR Award Read More »
New ISSCR President, Dr. Janet Rossant, kindly agreed to do an interview with me focused on the future of ISSCR, her plans for her tenure, and some key issues in the field. Dr. Rossant is Chief of Research at The Hospital for Sick Children in Toronto. 1. The stem cell arena is a very rapidly changing one
The ISSCR Annual Meeting will be held In Boston, MA in June. In advance of the meeting I was looking through the Preliminary Program that showed up in my mail box and then I checked out the confirmed speakers page on the web. What a cool lineup of speakers, I thought, but something seemed different….at
ISSCR Breaks Tradition with 2013 Annual Meeting Read More »
I have an ongoing poll on people’s impressions of the big annual stem cell meeting, ISSCR 2012. I myself have been wishing I was in Japan for that meeting so I remain surprised at the trending of the poll toward the negative. By far the most common response has been a surprisingly ho-hum “so-so” evaluation
Wish list from 2012 attendees for ISSCR 2013: some crankiness Read More »
What is ISSCR doing about unproven stem cell clinics? One of the greatest and most infuriating ironies of the stem cell-based regenerative medicine universe is that while the FDA strictly regulates the progress of therapy development by Advanced Cell Technology (ACT) and Geron and other legitimate companies, at the same time mysteriously the FDA essentially
ISSCR KO’d in round one versus unproven clinics: where’s the FDA? Read More »